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The effect of dibutyryl cyclic AMP and theophylline on lipoprotein lipase secretion was investigated after 
a 24 h pretreatment of human monocyte-derived macrophages. Both the effecters decreased in a dose-depen- 
dent manner the enzyme activity recovered in the culture medium. The decrease in lipoprotein lipase activity 
appeared to be related to reduced enzyme synthesis without apparent modification of its stability and half- 
life and was conversely associated with an increase of lysosomal acid hydrolase activities. This effect was 
reversible on removal of the nucleotide. The present findings suggest that cyclic AMP may play a role in 
lipoprotein lipase expression in human macrophages and therefore may participate in the regulation of lipo- 
protein uptake by these cells, which are strongly implicated in the atherogenic process. 
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1. INTRODUCTION 
The monocytic origin of foam cells found in 
atherosclerotic lesions has been demonstrated 
recently [l]. The activity of lipoprotein lipase 
(LPL), the key enzyme of triglyceride-rich lipopro- 
tein degradation is altered in these lesions [2]. 
Human monocyte-derived macrophages (H- 
MDM) synthesize and secrete LPL during their dif- 
ferentiation in vitro. Most of the synthesized en- 
zyme (about 80%) is found in the culture medium 
[3-61. Cyclic 3 ’ :5 ’ -adenosine monophosphate 
(CAMP), which is the intracellular messenger of 
the action of several hormones, has been shown to 
play an important role in LPL regulation in several 
tissues or cell lines [7-l 11. Thus it was of interest 
to determine whether the regulation of LPL in H- 
MDM involves CAMP. 
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In the present study, we describe a dose- 
dependent inhibition of LPL synthesis by dibutyryl 
cyclic AMP (DbcAMP) and theophylline in H- 
MDM without apparent modification of the en- 
zyme characteristics. 
2. MATERIALS AND METHODS 
2.1. Monocyte-derived macrophage culture 
Human monocytes from healthy subjects were 
isolated from buffy coat obtained after erythrocyte 
sedimentation using Dextran T 500 (Sigma) (1% 
final concentration). The leukocytes were washed 
once with Ca2+ and Mg*+ free phosphate buffered 
saline, pH 7.4 (PBS), layered over Lymphoprep 
(Nyegaard, Oslo, Norway, d = 1.007 g/ml) and 
centrifuged for 15 min at 400 x g at 18°C. 
Mononuclear cells were resuspended in RPM1 1640 
serum-free medium (IO’ cells/ml) and washed 
three times. Cells were plated on 35 mm gelatin- 
autologous plasma-coated Petri dishes following 
178 
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
00145793/87/$3.50 0 1987 Federation of European Biochemical Societies 
Volume 225, number 1,2 FEBS LETTERS December 1987 
the technique described by Freundlich and Av- 
dalovic [ 121. 1 ml mononuclear cell suspension was 
added to each dish and incubated for 90 min at 
37°C. Non-adherent cells were removed and the 
dishes washed three times with serum-free 
medium. The monolayer was reincubated with 
RPM1 1640 containing antibiotics (penicillin 
100 U/ml, streptomycin 100 pg/ml) and either 
20% autologous serum or 4% Ultroser G (IBF, 
France). Incubations with effecters were started 2 
days after plating and cells were harvested after a 
first 24 h preincubation period. 
At the end of incubation time, the medium was 
collected, frozen at -20°C and assayed for LPL 
activity within 1 week. 1 ml of a 1: 1 mixture of 
10 mM EDTA in Ca2+,Mg2+-free PBS with RPM1 
1640, 20% autologous serum was added for 
15 min to remove adherent cells. The cells were 
washed twice with Ca2+,Mg2+ PBS. The pellets 
were resuspended in the appropriate buffer, 
homogenized by sonication and protein determina- 
tion was performed by the method of Lowry et al. 
]131. 
2.2. Protein and LPL synthesis 
Cells were preincubated as described above. At 
the end of this period, medium was discarded and 
replaced with fresh medium containing 10 &i/ml 
[3H]leucine (CEA, France) and further incubation 
was performed for 3 h. Medium and cells were 
harvested as described above. Aliquots of medium 
were submitted to Sephadex Cl 50 chromatography 
in 4 M guanidinium chloride, 0.2 M leucine buffer 
to measure total secreted protein synthesis. 
Heparin-Sepharose chromatography was per- 
formed following the technique of Speake et al. 
[14] on a column equilibrated with 5 mM sodium 
barbital, pH 6.5, 20% glycerol, 0.1% (v/v) Triton 
X-100, and 50 mM NaCl. LPL was eluted by 
5 mM sodium barbital, pH 6.5, 20% glycerol, 
0.1% (v/v) Triton X-100 and 2 M NaCl. 
2.3. Assay of lipoprotein lipase activity 
The LPL assay system contained 0.1 ml of the 
culture medium and 0.05 ml of the substrate 
([ 14C]triolein/lecithin emulsion) prepared ac- 
cording to [16]. Incubations were carried out at 
37°C for 45 min. The reaction was stopped 
by addition of methanol/chloroform/heptane 
(1.4 : 1.25 : 1, v/v) and the fatty acid extraction per- 
formed according to Belfrage and Vaughan [17]. 
Enzyme activity was expressed as nmol free fatty 
acid released/mg cell protein per min. 
2.4. Lysosomal acid hydrolase assay 
/3-Galactosidase, hexosaminidase and p- 
glucuronidase activities were determined by a 
fluorometric assay in the culture medium and in 
the cell using the corresponding 4-methylum- 
belliferyl derivatives as substrate [ 151. 20 ~1 of 
substrate in appropriate buffer were mixed with 
either 20 ~1 of medium or 10 ,J of cell homogenate 
and incubations were carried out for 2 h at 37°C 
and stopped by adding 2 ml of 0.5 M Na2C03, pH 
11. Fluorescence was monitored on a Perkin-Elmer 
fluorometer at 360 nm excitation and 448 nm 
emission. 
3. RESULTS 
Preliminary studies showed that Ultroser G was 
almost as efficient as autologous serum in 
stimulating LPL release by macrophages (75-80% 
of serum values) and this serum substitute was 
therefore used in our experiments to standardize 
culture conditions. 
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Fig.1. Effect of DbcAMP (0) and theophylline (0) on 
LPL activity secreted by H-MDM. Cells were pretreated 
with the effecters during a first 24 h period in RPM1 
1640 supplemented with 4% Ultroser G and harvested 
after a second 24 h period in the same conditions. LPL 
was assayed in the medium as described in section 2. 
Each point is the mean + SE of four experiments in
duplicate (* p < 0.02, ** p < 0.01, *** p < 0.001 versus 
control). 
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As shown in fig. 1, the preincubation with either 
DbcAMP or theophylline produced, above 
10m5 M, a dose-dependent decrease in LPL activity 
recovered in the culture medium. Low concentra- 
tions of the effecters (about 10m5 M) caused a 
slight rise in LPL activity. The activity released in 
the medium over a 24 h period was more signifi- 
cant 4 days after plating than at day 8. However, 
the incubation of macrophages in the presence of 
10m4 M theophylline led to a similar decrease in 
LPL activity at both different stages of 
macrophages differentiation (not shown). 
In order to determine precisely the mechanism 
involved in the decrease in LPL activity found in 
the medium of treated macrophages, we measured 
the enzyme synthesis using [3H]leucine labelling 
and heparin-Sepharose separation. Treated cells 
showed a lowered [3H]leucine incorporation in 
2 M NaCl eluted fractions as well in the medium as 
in the cell lysate where the enzyme was not de- 
tectable (table 1). The ability of macrophages to 
synthesize and secrete proteins was conversely 
Table 1 
Effect of DbcAMP on incorporation of [3H]leucine into 
total secreted proteins and LPL in macrophages 
Control DbcAMP 
(1O-4 M) 
Total secreted 
proteins 74745 (100%) 99553 (133%) 
LPL 
Medium 2194 (100%) 757 ( 35%) 
Cells 393 (100%) ND 
&Galactosidase 
Medium 19.4 + 1.1 31.7 f 3.5b 
Cells 1.1 + 0.1 1.8 * 0.2’ 
Hexosaminidase 
Medium 387.9 f 26.9 590.6 + 31.9d 
Cells 31.2 f 3.3 36.1 f 0.9a 
,&Glucuronidase 
Medium 0.6 zk 0.3 1.1 + O.la 
Cells 1.0 * 0.1 2.1 * O.ld 
Results are expressed in cpm/mg cell protein and 
represent the mean of two separate experiments (ND, 
not detectable). Lysosomal acid hydrolase activities in 
control and DbcAMP-treated cells are expressed in 
arbitrary fluorescence units perpg cell proteins (mean + 
SE of six determinations). a p < 0.05, b p < 0.02, c p < 
0.01, d p < 0.001 versus control 
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slightly enhanced in DbcAMP-treated cells as were 
the measured lysosomal acid hydrolase activities 
(X 1.6, x 1.5, x 1.8 in medium and x 1.6, x 1.2, 
x 2 in cells for P-galactosidase, hexosaminidase 
and ,&glucuronidase, respectively) (table 1). In ad- 
dition, the secretion rate is diminished in treated 
cells as compared to control (fig.2). Although the 
inhibition was lower than after 24 h of treatment, 
the difference became significant within 2 h after 
medium change and increased all along the 8 h of 
incubation. 
In order to rule out the possibility of a general 
toxic effect of drugs on cultured cells, 24 h 
DbcAMP pretreated ishes were incubated in fresh 
medium in the presence or absence of the 
nucleotide. Dishes pretreated with DbcAMP were 
washed and reincubated in fresh medium devoid of 
effector. After an about 4 h lag period, the 
macrophages partially recovered their ability to 
secrete LPL in the medium. 24 h after DbcAMP 
removal, secretion returned to levels similar to 
those expressed in cells which have not been ex- 
posed to the nucleotide (fig.3). Furthermore, no 
difference could be detected either in the number 
of cells remaining at the end of the incubation time 
0 2 4 6 6 
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Fig.2. Effect of DbcAMP (10m4 M) on LPL activity 
secreted in the medium of cultured H-MDM. Cells were 
preincubated 24 h with (A) or without (A) DbcAMP. 
After medium change, cells were reincubated in the same 
conditions for 8 h and the medium was collected at the 
times indicated. LPL activity was assayed as described in 
section 2. Results are the mean + SE of four 
determinations (* p < 0.05, ** p < 0.01, *** p < 0.001 
versus control). 
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more, the absence of lipoproteins in this serum 
substitute demonstrated that these compounds are 
not required for enzyme expression. 
I 
8 24 
The decrease in LPL activity with high concen- 
trations of DbcAMP or theophylline is in good 
agreement with the findings for adipose tissue in 
vitro either by using theophylline [7] or under hor- 
monal stimulation [8]. In contrast, heart LPL has 
been shown by several authors to be enhanced by 
chemical or hormonal rise in CAMP intracellular 
level [9, lo]. 
The biphasic response of LPL to DbcAMP we 
found was also noted by Palmer et al. [9] in per- 
fused rat heart. A similar paradoxical effect of 
cyclic AMP has been shown for macrophage dif- 
ferentiation and inhibition of cytotoxicity [ 18,191. 
This biphasic effect could be dependent on the two 
different cyclic AMP-dependent protein kinases 
which are expressed in human macrophages [20]. 
Incubation time (hours) 
Fig.3. Effect of removal of DbcAMP on LPL activity 
secreted by H-MDM. Cells were preincubated during 
24 h in the presence of DbcAMP (10m4 M). After 
removal of the medium, cells were reincubated in 
medium with (Q) or without (81) DbcAMP. Control cells 
(0) were incubated in the same conditions without the 
nucleotide. Aliquots of medium were collected during 
the 24 h of further incubation and LPL activity was 
assayed as described in section 2. Results are the mean 
of duplicate dishes. 
or in total cell protein concentration (protein : con- 
trol, 64.4 f 11.7; theophylline, 66.5 f 14.7; 
DbcAMP, 65.3 + 6.0 pg/dish; cell counts (x 105): 
control, 3.2 f 0.2; theophylline, 2.8 f 0.7; 
DbcAMP, 3.2 +_ 0.2 cells/dish). 
To determine whether this decrease in LPL ac- 
tivity could also be related to an associated altera- 
tion of the enzyme stability in treated cells, we 
studied the decay of LPL activity in a cell-free 
system. There was no significant difference in the 
inactivation rate of enzyme isolated from control 
and 24 h DbcAMP preincubated cells. The ap- 
parent half-life of the enzyme in such conditions 
was 122 and 129 min for control and DbcAMP- 
treated cells, respectively (control: y = 0.146 + 
35.386, r = 0.987; DbcAMP: y = 0.076 + 19.576, 
r = 0.985). 
4. DISCUSSION 
Serum has been shown to be essential for LPL 
expression in human monocyte-derived macro- 
phages [6]. The use of the synthetic serum Ultroser 
G, which did not affect LPL secretion or cell 
viability, allowed one to minimize variations in cell 
culture conditions occurring with serum. Further- 
The fact that the decrease in LPL activity was 
reversed by removing effecters and that the 
nucleotide did not significantly affect the number 
of adherent cells or cell protein concentration sug- 
gested that this decrease was not related to a non- 
specific toxic effect. The lowering of LPL activity 
by DbcAMP or theophylline appears to be mainly 
due to a decrease in enzyme synthesis without 
significant alteration of LPL stability as assessed 
by in vitro half-life determination. Conversely, 
some other secreted proteins seemed to be enhanc- 
ed by this stimulation. 
A similar lowering effect on LPL activity in 
macrophages was obtained by LPS stimulation 
[21]. However this effector led also to a dramatic 
decrease of lysosomal acid hydrolase activities in 
medium and cell lysate [22]. In contrast, lysosomal 
acid hydrolase activities, which were assayed, were 
enhanced by DbcAMP at concentrations which 
decreased LPL without modification of their ratio. 
The same results were obtained with theophylline 
(not shown). This fact is in favour of a complex 
regulation of macrophage LPL depending on the 
kind of stimulation and therefore on the specialisa- 
tion acquired by the cell (i.e. cytotoxicity which is 
increased with LPS [23] and decreased by CAMP 
t19n. 
Incubation of macrophages with VLDL or 
chylomicrons led to lipoprotein uptake by the ,13- 
VLDL receptor which is present at the cell surface. 
Although not a prerequisite step in particle capta- 
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tion, the LPL-mediated degradation into remnant 
particles favors the enhancement of cholesterol 
cellular content [24,25]. CAMP has been shown to 
be specifically increased in atherosclerotic lesions 
of rabbits fed a high cholesterol diet [26]. Recent- 
ly, Jonasson et al. [27] demonstrated that LPL is 
not immunologically detectable in the lipid core of 
human atherosclerotic plaques. Conversely, ,& 
glucuronidase is enhanced in human athero- 
sclerotic aortas [28]. Our findings that CAMP 
dramatically decreases LPL synthesis and secretion 
by H-MDM is consistent with these observations. 
Thus the CAMP-mediated decrease of macrophage 
LPL could play a role in lipoprotein uptake and in 
foam-cell formation in atherosclerotic lesions. 
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